GWEP 1521: A double-blind, randomized, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P, CBD) as add-on therapy in patients with tuberous sclerosis complex who experience inadequately-controlled seizures

Project: Research project

Project Details

StatusActive
Effective start/end date5/9/188/31/50

Funding

  • GW Research Ltd
  • GW Research Ltd